NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Evolv Technologies Holdings, Inc. ("Evolv Technologies" or "the Company") (NASDAQ:EVLV). Investors who purchased Evolv Technologies securities prior to August 19, 2022, and continue to hold to the present, are […]

Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ: ARVN). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Arvinas and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vicor Corporation ("Vicor" or "the Company") (NASDAQ:VICR). Investors who purchased Vicor securities prior to April 26, 2023, and continue to hold to the present, are encouraged to obtain additional

Pomerantz LLP is investigating claims on behalf of investors ofSelectQuote, Inc.(“SelectQuote” or the “Company”)(NYSE: SLQT).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether SelectQuote and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the

Pomerantz LLP is investigating claims on behalf of investors ofGoHealth, Inc.(“GoHealth” or the “Company”)(NASDAQ: GOCO).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether GoHealth and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the

Pomerantz LLP is investigating claims on behalf of investors ofHumana Inc.(“Humana” or the “Company”)(NYSE: HUM).Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Humana and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the

Pomerantz LLP is investigating claims on behalf of investors of Bausch + Lomb Corporation(“Bausch + Lomb” or the “Company”) (NYSE: BLCO). Such investors are advised to contact DaniellePeyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Bausch + Lomband certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Pomerantz LLP is investigating claims on behalf of investors of Wabash National Corporation (“Wabash” or the “Company”) (NYSE: WNC). Such investors are advised to contact DaniellePeyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Wabashand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information

Pomerantz LLP is investigating claims on behalf of investors of Amerant Bancorp Inc.(“Amerant” or the “Company”) (NYSE: AMTB).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Amerant and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

Pomerantz LLP is investigating claims on behalf of investors of FTI Consulting, Inc.(“FTI” or the “Company”) (NYSE: FCN).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether FTI and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for